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Abstract A high affinity molecular interaction is demonstrated
between calsequestrin and the sarcoplasmic reticular Ca2+
release channel/ryanodine receptor (RyR) by surface plasmon
resonance. KD values of 92 nM and 102 nM for the
phosphorylated and dephosphorylated calsequestrin have been
determined, respectively. Phosphorylation of calsequestrin seems
not to influence this high affinity interaction, i.e. calsequestrin
might always be bound to RyR. However, the phosphorylation
state of calsequestrin determines the amount of Ca2+ released
from the lumen. Dephosphorylation of approximately 1% of the
phosphorylated calsequestrin could be enough to activate the
RyR channel half-maximally, as we have shown previously
[Szegedi et al., Biochem. J. 337 (1999) 19].
z 2000 Federation of European Biochemical Societies.
Key words: Sarcoplasmic reticulum; Ca2 release;
Ryanodine receptor; Calsequestrin; Striated skeletal muscle;
Surface plasmon resonance
1. Introduction
Skeletal muscle calsequestrin, the major Ca2 storage pro-
tein within the cisternae of the sarcoplasmic reticulum (SR),
binds and releases approximately 50 Ca2 ions per molecule
during each relaxation^contraction cycle [1]. This high ca-
pacity but low a⁄nity Ca2 binding protein is located in close
proximity to the Ca2 release channel/ryanodine receptor
(RyR). Electron microscopy reveals calsequestrin as elec-
tron-dense material which is connected to RyR by ‘anchoring
strands’ [2] or ‘rope-like ¢bers’ [3].
In recent years this structural organization has increasingly
attracted attention and has led to assumptions of a functional
signi¢cance of the above morphological arrangement and the
existence of a coordinated process between luminal events and
the cytosolic response.
In addition to the calcium bu¡ering role of calsequestrin in
the SR lumen, several strands of evidence predict that this
acidic protein in£uences the Ca2 release/RyR channel activ-
ity. Biochemical experiments have given ¢rst hints that calse-
questrin is involved in regulating the released amount of Ca2
through the RyR [4^6], which might occur indirectly by two
further junctional integral membrane proteins, such as triadin
[7,8] or junctin [9,10]. Murray and Ohlendieck, however, re-
ported a direct complex formation between calsequestrin and
RyR without detectable amounts of triadin being involved in
the complex formation [11].
Our recent paper [12] con¢rms the e¡ect of calsequestrin on
the SR Ca2 release channel. Moreover, we could show that
calsequestrin, depending on its phosphorylation state, selec-
tively controls the RyR channel activity. In the presence of 1
mM luminal Ca2 only the dephosphorylated calsequestrin
induces Ca2 release from the SR lumen, whereas the
phosphorylated form has no e¡ect. Our results have demon-
strated for the ¢rst time that the luminal phosphorylation/
dephosphorylation system contributes to the regulation of
the Ca2 release process [12].
The existence of an endogenous phosphorylation system in
the SR lumen has already been reported before (for review
[13]) : we described ¢rst [14] that calsequestrin can be
phosphorylated and the isolated calsequestrin from rabbit
skeletal muscle can be obtained in fully or partly phosphory-
lated forms [15]. Furthermore, two luminally located glyco-
proteins, sarcalumenin and the histidine-rich Ca2 binding
protein [16^19], can also be phosphorylated, thereby modulat-
ing the RyR activity [19,20]. The protein kinase responsible
for the phosphorylation of these intraluminal proteins is ca-
sein kinase II, which has been shown to be located in the
lumen [18,21]. The phosphate donor necessary for these phos-
phorylation processes is ATP which can be transported
through an SR voltage-dependent anion channel/porin-like
protein [22].
In the present work we will show a high a⁄nity molecular
interaction between the phosphorylated and dephosphorylated
calsequestrin and RyR. However, no interaction could be ob-
served between calsequestrin and the putative intraluminal
RyR loops, M1/2 (aa 4580^4639) and M3/4 (aa 4860^4917).
2. Materials and methods
2.1. Preparations
Heavy SR vesicles and RyR were prepared exactly as described [12].
Mouse monoclonal IgM antibodies against rabbit skeletal muscle
RyR (lot 16534) were purchased from Biomol (Germany).
Calsequestrin was isolated from the protein^glycogen complex as
described previously [14,23]. Phosphorylation of calsequestrin by ca-
sein kinase II was carried out as reported before [12].
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2.2. Cloning, overexpression and puri¢cation of the two putative luminal
loops of the RyR
The two putative luminal loops M1/2 (aa 4580^4639) and M3/4 (aa
4860^4917) were ampli¢ed via RT-PCR from skeletal muscle mRNA.
First strand synthesis was carried out using a primer (5P-
TGCTCCTGCTGGT-3P) derived from bases 14 832^14 850. The
PCR of the M1/2 loop DNA was done using two primers (5P-
GGAATTCCTCCATGTAGCCCGTGCTCT-3P, 5P-CGGATCCAG-
GTCTCAGACTCTCCACC-3P) and PCR of the M3/4 loop DNA
was carried out with the primers 5P-CGGGATCCGCAAGTTCTA-
CAACAAGAG-3P and 5P-GGAATTCGTCGAAGACCACCCGG-
TAGA-3P introducing the restriction sites BamHI and EcoRI into
both PCR products. The loops were cloned into the pGEX-5X-1
(Pharmacia) via the restriction sites. They were transformed into com-
petent Escherichia coli BL21DE3 cells and plated on ampicillin con-
taining Luria^Bertani/agar plates (Difco). 500 ml ampicillin contain-
ing Luria^Bertani broth medium was inoculated from the plates and
peptide overexpression was induced using 0.5 mM IPTG (isopropyl-L-
D-thiogalactopyranoside, Sigma) at 37‡C. The glutathione S-transfer-
ase (GST) fusion peptides were puri¢ed using glutathione-Sepharose
according to the instructions of Pharmacia.
2.3. Surface plasmon resonance (SPR)
SPR studies were carried out using a BIAcore 2000 instrument
(Biacore AB, Uppsala, Sweden). The ligands were immobilized onto
a CM5 sensor chip (Biosensor) either directly, covalently via primary
amines or indirectly, site speci¢cally onto an K-GST antibody surface
via a GST fusion tag.
Calsequestrin was immobilized using a standard amine coupling in
a bu¡er containing in 500 mM NaCl, 100 WM CaCl2 and 50 mM
HEPES pH 8.2. The association and dissociation of RyR were deter-
mined on a surface containing 800 response units (RU) of calseques-
trin. The running bu¡er for the interaction studies between RyR and
calsequestrin contained 150 mM KCl, 50 mM HEPES pH 7.2, 100
WM CaCl2, 0.5% CHAPS and 1 mM DTE. RyR in a concentration
range of 5^160 nM was injected as analyte onto the calsequestrin
loaded surface with a £ow rate of 10 Wl/min at 20‡C. Both the in-
jection and dissociation times were 700 s. The regeneration of the
calsequestrin surface, i.e. the removal of the bound RyR, was per-
formed using 0.2% SDS resulting in a completely regenerated surface.
The surface could be used three times without losing its binding ac-
tivity. After three experiments a new sensor surface was prepared.
To determine whether the calsequestrin bound protein is really the
RyR, antibodies against the RyR were injected during the dissociation
phase (for details see the legend of Fig. 3). The increase in response is
due to an enhancement of the surface concentration and is the evi-
dence for binding of antibodies to the RyR bound on the immobilized
calsequestrin.
Chase experiments were performed to check if rebinding a¡ects the
dissociation kinetics. For these chase experiments ¢rst RyR was in-
jected onto surfaces containing immobilized dephosphorylated or
phosphorylated calsequestrin. Then, during the dissociation phase de-
phosphorylated or phosphorylated calsequestrin (1^20 WM)) was in-
jected.
The data evaluation was carried out using the software program
BIAevaluation version 3.0.
The kinetic constants were calculated by non-linear regression of
data using the pseudo ¢rst order rate equation.
R  kassCRmax=kassC  kdissU13e3kassCkdisst
where R is the SPR signal in RU, kass is the association rate constant,
kdiss is the dissociation rate constant and C is the concentration of the
injected analyte.
The dissociation rate constant was calculated using the following
equation:
Rt  R0 e3kdisst3t0
where Rt is the response signal at a time t and R0 is the response
signal at the start time t0.
The dissociation constant was calculated according to the following
equation:
KD  kdiss=kass
3. Results and discussion
The molecular interaction between an immobilized compo-
nent, referred to as the ligand, and a molecule in the mobile
phase, designated the analyte, was determined by SPR studies
in the BIAcore instrument. Changes in surface concentration
are proportional to changes in the refractive index on the
surface which results in changes in the SPR signal; these are
plotted as RU as a function of time. 1000 RU corresponds to
a surface concentration of 1 ng/mm2 [24].
Representative sensorgrams in Fig. 1 demonstrate the inter-
action between calsequestrin and RyR. Panels A and B show
the binding curves that are the result of an interaction be-
tween the dephosphorylated (A) or the phosphorylated calse-
questrin (B) and RyR in di¡erent concentrations. Panels D
(refers to A) and E (refers to B) represent the corrected data
after determining and subtracting the control values shown in
panel C. During the binding of RyR to dephosphorylated or
phosphorylated calsequestrin, a quasi saturation phenomenon
was observed at concentrations higher than 40 nM RyR.
Therefore, association rate constants were calculated with
RyR concentrations between 5 and 40 nM. Covalently, 800
RU calsequestrin (17.8 fmol/mm2) was immobilized to the
chip surface and this immobilized calsequestrin bound up to
2200 RU monomer RyR (3.9 fmol/mm2).
These measurements were carried out at a ¢xed [Ca2] of
about 100 WM. This [Ca2] should induce a de¢ned confor-
mation state of calsequestrin which allows the protein to par-
ticipate in protein^protein interactions [25]. Moreover, at rest
the in situ free [Ca2] of SR was calculated to be about 3.6
mM, thus, calsequestrin is largely saturated with Ca2 in the
SR lumen [26].
Using a series of di¡erent concentrations of RyR, the asso-
ciation rate constant was calculated as described in Section 2.
For the interaction of the phosphorylated calsequestrin with
RyR a kass of 1.23U105 M31 s31 and for that of dephosphor-
ylated calsequestrin a kass of 1.35U105 M31 s31 was obtained.
Rebinding is known to be a common problem in the anal-
ysis of the dissociation phase. Therefore, additional chase ex-
periments were carried out by injecting dephosphorylated or
phosphorylated calsequestrin during the dissociation phase.
Fig. 2A,B shows a representative set of these chase experi-
ments. Addition of 1 WM calsequestrin indeed increases the
dissociation rate approximately two-fold, there is only a mar-
ginal further increase by enhancing [calsequestrin] up to 20
WM. There is essentially no di¡erence between the e¡ects of
phosphorylated and dephosphorylated calsequestrin as ligand
or as chasing agent, respectively (compare Fig. 2A and B).
The upper curves without label show the unchased dissocia-
tion phase. As can be seen during the dissociation phase RyR
itself seems to rebind to the calsequestrin surface. Therefore,
to calculate the dissociation rate constants the chase experi-
ments were chosen: kdiss values of 0.0113 s31 and 0.0137 s31
for the phosphorylated and dephosphorylated calsequestrin,
respectively, were calculated.
In order to prove that the bound protein is RyR on the
immobilized calsequestrin, RyR antibodies were injected dur-
ing the dissociation phase. Fig. 3 shows the interaction of
anti-RyR with the RyR^calsequestrin complex. The binding
curves indicate that the calsequestrin bound protein is the
RyR (for experimental details see legend of Fig. 3).
Table 1 summarizes the association and dissociation rate
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constants and the equilibrium binding constants for the inter-
action of dephosphorylated or phosphorylated calsequestrin
with RyR. The calculated KD for the interaction of the RyR
with the dephosphorylated calsequestrin is 102 nM using a
kass of 1.35U105 M31 s31 and a kdiss of 0.0137 s31 ; for the
interaction with the phosphorylated calsequestrin it is 92 nM,
applying a kass of 1.23U105 M31 s31 and a kdiss of 0.0113 s31.
Both sets of rate constants, for the dephosphorylated and for
the phosphorylated calsequestrin, were in the same range.
This observation indicates that calsequestrin phosphorylation
has no e¡ect on the molecular interaction of calsequestrin
with RyR. In contrast, phosphorylation of calsequestrin con-
trols the amount of released Ca2 from the lumen through the
RyR as our recent electrophysiological measurements have
revealed [12] ; i.e. calsequestrin phosphorylation does not
change the overall a⁄nity of calsequestrin to RyR, it exerts
a much more subtle e¡ect on the interaction of these two
proteins.
To see whether the two putative luminal RyR loops, M1/
M2 and M3/M4, are involved in the speci¢c interaction of the
RyR with calsequestrin these RyR luminal loops (Fig. 4) were
expressed as GST fusion proteins and were immobilized on a
CM5 chip. Calsequestrin was injected as an analyte onto these
surfaces with the aim of invoking changes in the refractive
index as a result of a potential protein^protein interaction.
No speci¢c interaction has been observed (not shown). There
Fig. 1. RyR binds with a high a⁄nity to phosphorylated and dephosphorylated calsequestrin. Phosphorylated and dephosphorylated calseques-
trin were immobilized on a CM5 chip as described in Section 2. The association and dissociation phases of the interaction with RyR were
monitored by following changes in the SPR signal, given in RU. The upper curves show the interaction of the RyR with dephosphorylated (A)
and phosphorylated (B) calsequestrin. For a negative control the RyR was injected onto an activated and then deactivated CM5 surface (C).
No non-speci¢c interaction was detected between the RyR and the CM5 chip surface. After subtracting the bulk changes (C) from A or B, re-
spectively, the speci¢c interactions between the dephosphorylated (D) or phosphorylated (E) calsequestrin and RyR are shown.
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are several possibilities that could explain these results: the
expressed polypeptides might fold di¡erently in comparison to
the native protein and thus the binding domain is either not in
the right conformation or not accessible. Other possibilities
are that the calsequestrin interaction site might not be local-
ized on the tested putative loops, or the interaction of the
calsequestrin with the RyR occurs indirectly, via an as yet
unknown and unidenti¢ed component which could be present
in our RyR preparation.
One of the potential candidates might be triadin which has
been intensively studied and controversially discussed in the
literature as a possible link in the interaction between calse-
questrin and RyR. Fan et al. [27] have proposed a model in
which the cytoplasmic region of triadin, aa 110^163, interacts
with RyR at the cytoplasmic side. This was further supported
by Ohkura et al. [28]. Recently, Groh et al. [29] reported that
a small cytoplasmic region of triadin (aa 18^46) interacts with
RyR; a direct molecular interaction of this domain with RyR
was con¢rmed by overlay assays, SPR studies and by RyR
channel activity measurements in planar lipid bilayers. On the
other hand, Froemming et al. [30] reported that although
triadin exists in the near vicinity of the RyR channel tetramer,
it does not seem to be directly linked to the other main triadic
components; the proposed role of triadin should be the main-
tenance of the overall triadic architecture. Actually, Murray
and Ohlendieck [11] have shown that calsequestrin is directly
coupled to the RyR. Also morphological studies provide
strong evidence for a direct connection of calsequestrin to
RyR [31].
Our RyR, prepared according to standard procedure, is
enriched with the channel protein to approximately 90% and
the main component of the 10% contamination is the SR
Ca2 transport ATPase. Coomassie brilliant blue stained
SDS^PAGE gels show in the range of 95k polypeptide(s)
present in an amount of ca. 1% which could include triadin,
however, its presence alone would not allow us to draw con-
clusions about its interaction with other triadic proteins. On
the basis of SPR studies here we demonstrate an interaction
with high a⁄nity in the nM range without being able to de-
cide whether the interaction of calsequestrin with RyR occurs
directly or indirectly. Obviously, phosphorylation of calse-
questrin has no in£uence on this high a⁄nity molecular inter-
action. It means that calsequestrin might always be bound on
the SR Ca2 release channel and actually, the phosphory-
Fig. 2. Chase experiments reveal the rebinding of the RyR to calse-
questrin. Approximately the same amount of RyR (40 nM) was in-
jected onto a CM5 chip with immobilized dephosphorylated (A)
and phosphorylated (B) calsequestrin on it. Di¡erent concentrations
of dephosphorylated (CSQ) and phosphorylated calsequestrin (P-
CSQ) were included during the dissociation phase. As a control the
RyR was injected onto an activated and then deactivated surface.
Panels A and B show the corrected binding, i.e. following subtrac-
tion of the control values. The upper curves without label show the
unchased dissociation phase. A relative RU of 1 corresponds to 800
RU or 700 RU dephosphorylated or phosphorylated calsequestrin^
RyR complex on the surface, respectively.
Fig. 3. Antibody against the RyR proves the interaction of the RyR
with calsequestrin. During each cycle approximately the same
amount of RyR (40 nM) was injected onto a CM5 chip with immo-
bilized dephosphorylated calsequestrin on it. After the end of the in-
jection anti-RyR antibodies were included during the dissociation
phase in 500- or 1000-fold dilution. To control for non-speci¢c
binding, the RyR antibody was injected over a calsequestrin loaded
surface: no non-speci¢c binding could be detected (data not shown).
The curves before addition of antibodies show the initial dissocia-
tion phase in the absence of RyR antibodies.
Table 1
Kinetic parameters determined by SPR measurements
Interaction of RyR with kass (M31s31) kdiss (s31) KD (nM)
Dephosphorylated calsequestrin 1.35U105 0.0137 101.5
Phosphorylated calsequestrin 1.23U105 0.0113 91.9
Data of representative sensorgrams on the interaction between calsequestrin and RyR were evaluated as described in Section 2.
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lation state of calsequestrin could determine the amount of
Ca2 released from the lumen. On the basis of our electro-
physiological studies in [12] the dephosphorylation of approx-
imately 1% of phosphorylated calsequestrin might be enough
to activate the RyR channel half-maximally presumably with-
out dissociating from it.
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